The CD8 receptor is a protein on the surface of certain immune cells that acts as a coreceptor, helping T cells recognize and kill infected or abnormal cells. It works alongside the T cell receptor (TCR) by binding to a specific molecule on the surface of nearly every cell in your body, stabilizing the connection and amplifying the activation signal. Without CD8, T cells would struggle to detect threats at the low concentrations typically found during real infections. In fact, CD8 enhances a T cell’s sensitivity to its target by roughly a millionfold.
How CD8 Helps T Cells Lock Onto Targets
Every nucleated cell in your body displays small protein fragments on its surface using a molecule called MHC class I. These fragments are like an inventory list of what the cell is making. If a virus has hijacked the cell, viral protein fragments show up on that list. The T cell receptor scans these fragments, but on its own, the TCR binds weakly to most targets. CD8 solves this problem by simultaneously grabbing onto the MHC class I molecule itself, reinforcing the connection.
CD8 binds to a region of MHC class I that sits below the groove where protein fragments are displayed. Specifically, it contacts the alpha 2 and alpha 3 domains of the MHC class I heavy chain, nestling into a cavity formed by the platform of the molecule and a smaller supporting protein called beta-2 microglobulin. This binding doesn’t interfere with the TCR’s ability to read the protein fragment. Instead, it locks the T cell and its target together long enough for activation to begin.
Structure of the CD8 Molecule
CD8 exists as a pair of protein chains linked together at the cell surface. It comes in two forms: a pairing of two identical alpha chains (called an alpha-alpha homodimer), or a pairing of one alpha chain with one beta chain (called an alpha-beta heterodimer). Each chain has an antibody-like domain at its tip, a stalk connecting it to the cell membrane, and a short tail that extends inside the cell.
The two forms are not interchangeable. The alpha-beta version is the one found on conventional cytotoxic T cells in your blood and lymph nodes. It focuses its grip tightly on the alpha 3 domain of MHC class I, creating a smaller but more precise contact area of about 963 square angstroms. The alpha-alpha version, found on some other immune cells like certain intestinal T cells and natural killer cells, makes broader contact across multiple domains, burying a much larger surface area of 1,300 to 1,850 square angstroms. This structural difference reflects their distinct biological roles: the alpha-beta form is optimized to work with the TCR during antigen-specific killing, while the alpha-alpha form serves broader surveillance functions.
Triggering the Activation Signal
Binding to MHC class I is only half of CD8’s job. The other half happens inside the cell. The cytoplasmic tail of the CD8 alpha chain is physically attached to a signaling enzyme called Lck (a tyrosine kinase). When CD8 and the TCR both grab onto the same MHC class I molecule on a target cell, they are pulled close together. This brings Lck right next to the internal signaling components of the TCR complex.
Once in position, Lck adds phosphate groups to specific parts of the TCR’s internal chains, acting like a molecular ignition switch. This kicks off a cascade of chemical signals inside the T cell that ultimately leads to full activation: the cell begins dividing, producing inflammatory molecules, and assembling its killing machinery. Without CD8 delivering Lck to the right spot, T cells responding to typical viral or self-derived protein fragments simply cannot generate a strong enough signal to activate. Only T cells with unusually high-affinity TCRs (binding strengths below about 3 micromolar) can function without CD8, and those are rare.
What Activated CD8+ T Cells Do
Once a CD8+ T cell is activated, it becomes a cytotoxic (cell-killing) effector. It destroys infected or abnormal target cells using two main weapons. The first is perforin, a protein that punches holes in the target cell’s membrane. The second is a family of enzymes called granzymes, primarily granzyme A, granzyme B, and granzyme K. Granzymes enter through the perforin pores and trigger programmed cell death from the inside, essentially forcing the infected cell to self-destruct.
Activated CD8+ T cells also release signaling molecules like interferon-gamma and TNF, which alert neighboring cells to the infection and recruit additional immune responders. A surface marker called CD107a appears on CD8+ T cells when they are actively releasing their killing granules, and researchers use it as a measure of how aggressively the cells are fighting. Beyond granzymes’ role inside target cells, these enzymes also have extracellular effects that promote immune cell migration and inflammation at the infection site.
CD8+ T Cells in Viral Infections
CD8+ T cells are essential for clearing many viral infections, particularly in the lungs. In mouse studies, they are critical for eliminating influenza, respiratory syncytial virus (RSV), and human metapneumovirus. When researchers transferred virus-specific CD8+ T cells into infected mice, lung viral levels dropped significantly. Immunization strategies targeting CD8+ T cell responses also reduced viral loads following influenza, RSV, and even SARS coronavirus challenges.
Memory CD8+ T cells, the long-lived cells that remain after an infection resolves, express high levels of adhesion molecules that help them quickly reach infected tissue during reinfection. They also maintain the ability to rapidly produce granzyme B and inflammatory cytokines upon re-encountering their target. This is why prior exposure to a virus often results in faster clearance the second time around: your CD8+ memory cells are already primed and waiting.
How CD8+ T Cells Develop
CD8+ T cells are born in the thymus, where immature T cells initially express both CD4 and CD8 on their surface. These “double-positive” cells undergo a selection process. If a cell’s TCR successfully recognizes MHC class I molecules (the type CD8 binds), it receives survival signals and eventually shuts off CD4 expression, committing to the CD8+ cytotoxic lineage. Cells whose TCRs instead recognize MHC class II molecules keep CD4 and become helper T cells.
The decision between these two fates is not as straightforward as it might seem. Research has shown that artificially shutting off CD4 immediately after selection can misdirect cells into the cytotoxic lineage regardless of which MHC class they recognized, highlighting that positive selection and lineage commitment are distinct steps. The duration and strength of signaling through CD4 versus CD8, rather than a single binary switch, shape which type of T cell ultimately emerges.
Normal CD8+ T Cell Counts
In healthy adults, CD8+ T cell counts typically range from about 280 to 880 cells per microliter of blood, with average values around 540 cells per microliter. Men tend to have slightly higher counts than women. These numbers vary by population: studies in Chinese adults found average CD8+ counts of about 540 cells per microliter, compared to roughly 593 in Caucasian populations. The ratio of CD4+ to CD8+ T cells (the CD4/CD8 ratio) normally sits around 1.5, meaning you have about 50% more helper T cells than cytotoxic T cells in circulation at any given time.
Shifts in this ratio can signal immune problems. A dropping CD4/CD8 ratio is a hallmark of HIV infection, where CD4+ cells are progressively destroyed. An unusually high CD8+ count can occur during active viral infections as the body ramps up its cytotoxic response. Clinicians use these counts alongside other markers to assess immune function in conditions ranging from chronic infections to immunodeficiency disorders and post-transplant monitoring.